Graphite Bio Inc (GRPH) Financials

$22.26

$0.00 (0.00%)

As on 22-Mar-2024 09:30EDT

Market cap

$185 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	2.41	8.35	0.73	0.12	--	--
Gross Profit	-2.41	-8.35	-0.73	-0.12	--	--
Operating Expenses	70.70	105.64	60.44	13.50	0.03	--
Operating Profit (EBIT)	-73.11	-105.64	-60.44	-13.50	-0.03	--
Other Income	--	4.59	-10.32	--	--	--
Profit before Tax	-124.65	-101.05	-70.76	-68.37	-0.11	--
Provision for Tax	--	-4.59	-11.05	-54.79	0.08	--
Profit after Tax (Net Income)	-124.65	-96.47	-59.71	-13.58	-0.19	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-101.05	-70.76	-68.37	-0.11	--

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	183.58	296.29	384.05	-65.41	-2.22	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.08	12.57	5.79	55.92	2.21	--
Current Liabilities	4.80	13.04	12.14	32.05	2.22	--
Total Liabilities	188.46	321.90	401.99	22.56	0.01	--

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.44	46.54	20.25	1.46	--	--
Current Assets	188.02	275.37	381.74	21.10	0.01	--
Total Assets	188.46	321.90	401.99	22.56	0.01	--
Total Debt*	0.36	5.79	11.28	--	2.21	--
Net Current Assets	183.22	262.32	369.59	-10.95	-2.22	--

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-90.01	-87.98	-52.85	-8.72	-0.02	--
Cash Flow from Investing Activities	--	-241.86	-5.74	-1.55	-1.55	--
Cash from Financing Activities	0.19	0.60	417.47	30.08	30.08	--
Net Cash Inflow / Outflow	--	-329.25	358.88	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-2.15	-1.73	-1.12	-0.40	--	--
Cash EPS ($)	-2.10	-1.69	-1.10	-0.39	--	--
Adjusted Book Value ($)	3.16	5.32	7.19	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.55	-1.58	-0.99	-0.26	--	--
Free Cash Flow per Share ($)	-1.74	-1.70	-1.10	-0.30	--	--

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-51.29	-27.66	-36.20	41.52	--	--
ROE (%)	-51.95	-28.36	-37.48	40.16	--	--
ROA (%)	-48.85	-26.65	-28.13	-120.34	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	-2,103.01	578.74	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	30.79	-74.77	-347.73	-46,451.72	--	--
Net Profit Growth (%)	-29.22	-61.56	-339.68	-7,085.19	--	--
EPS Growth (%)	-0.24	-0.55	-1.81	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-1.22	-1.92	-11.12	--	--	--
Price / Book Value	0.83	0.62	1.73	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.47	0.75	-4.22	--	--	--
Close Price ($)	18.34	23.24	87.01	--	--	--
High Price ($)	24.01	93.73	238.00	--	--	--
Low Price ($)	11.13	14.49	56.77	--	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.00	0.02	0.03	--	-0.99	--
Short term debt to equity ratio	0.00	0.01	0.01	--	-0.99	--
Current Ratio	39.20	21.11	31.44	0.66	0.00	--
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	-23.03	-5.47	-337.50	-0.36	--

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	216.84	110.74	767.07	950.86	--	--
Cash Conversion Cycle	--	--	--	--	--	--